2026年7月29日 17:53 ET 发布 · 更新于 3 个月前 · 1 个来源
Goldman-Backed Biotech Attovia Seeks $212.5 Million in US IPO
bloomberg
·
原始报道
Attovia Therapeutics Inc., an early-stage drug developer focused on immune-mediated diseases with high unmet need, is seeking to raise as much as $212.5 million in a US initial public offering.
原文